文献速递哮喘慢阻肺

健康差异:肺部疾病干预措施——一项叙述性综述

Health Disparities: Interventions for Pulmonary Disease - A Narrative Review.
PubMed 文献 · Chest · 2023-02-27

该叙述性综述检索并分析了211篇关于减少美国医疗体系中肺部疾病健康差异(涉及种族、收入或性别)的干预研究,将其分为生物、教育、行为和结构性四类。主要发现包括:干预试验数量远少于差异描述性研究、哮喘领域黑人低收入城市患者被过度代表、种族或社会经济地位并非个体药物反应的有效标志、远程医疗有助于扩大护理规模但需进一步研究、未来干预须明确针对社会驱动因素而非仅个体行为、干预需根据本地需求定制。

要点

  • 肺部疾病健康差异干预试验数量远少于差异描述性研究,哮喘领域黑人低收入城市患者被过度代表。
  • 种族或社会经济地位不是个体药物治疗反应的有效标志。
  • 未来干预须针对社会驱动因素而非仅个体行为,并根据本地需求定制。

核心结论

  • 肺部疾病健康差异的干预研究存在明显缺口,未来需开展针对社会驱动因素、适应当地需求的高质量干预试验。

研究设计与样本

  • 叙述性综述,检索并分析了211篇关于减少美国医疗体系中肺部疾病健康差异(涉及种族、收入或性别)的干预研究文章。

主要发现

  • 干预试验数量远少于描述健康差异的研究,且涉及黑人、低收入、城市居住的哮喘患者的试验被过度代表。
  • 种族或社会经济地位不是个体药物治疗反应的有效标志。
  • 远程医疗有助于扩大护理规模,但需进一步研究如何利用远程医疗改善边缘化社区的结果。
  • 未来干预必须明确针对社会差异驱动因素,而非仅关注个体行为。
  • 个体干预只有针对当地需求定制才能达到最大效果。

临床怎么用

  • 临床实践中应认识到种族或社会经济地位不能作为个体药物选择的依据。
  • 设计或选择干预措施时需考虑社会驱动因素,并根据本地需求进行定制。

局限性

  • 文献中干预试验数量少,且哮喘以外的疾病研究不足。
  • 缺乏高质量有效性试验,且对如何实施已验证干预(平衡原始方案忠实度与适应当地障碍)的理解有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

There is expansive literature documenting the presence of health disparities, but there are disproportionately few studies describing interventions to reduce disparity. In this narrative review, we categorize interventions to reduce health disparity in pulmonary disease within the US health care system to support future initiatives to reduce disparity. We identified 211 articles describing interventions to reduce disparity in pulmonary disease related to race, income, or sex. We grouped the studies into the following four categories: biologic, educational, behavioral, and structural. We identified the following five main themes: (1) there were few interventional trials compared with the breadth of studies describing health disparities, and trials involving patients with asthma who were Black, low income, and living in an urban setting were overrepresented; (2) race or socioeconomic status was not an effective marker of individual pharmacologic treatment response; (3) telehealth enabled scaling of care, but more work is needed to understand how to leverage telehealth to improve outcomes in marginalized communities; (4) future interventions must explicitly target societal drivers of disparity, rather than focusing on individual behavior alone; and (5) individual interventions will only be maximally effective when specifically tailored to local needs. Much work has been done to catalog health disparities in pulmonary disease. Notable gaps in the identified literature include few interventional trials, the need for research in diseases outside of asthma, the need for high quality effectiveness trials, and an understanding of how to implement proven interventions balancing fidelity to the original protocol and the need to adapt to local barriers to care.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Harper LJ, Kidambi P, Kirincich JM, et al. Health Disparities: Interventions for Pulmonary Disease - A Narrative Review. Chest. 2023. PMID: 36858172. doi:10.1016/j.chest.2023.02.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。